sonar-pro
Permits stability data submission for pharmaceutical products at 25°C/60% relative humidity (RH) when supported by accelerated stability studies.
{
  "id": "48a186cb-7c3d-491d-8b0c-1a0885428e2c",
  "choices": [
    {
      "finish_reason": "stop",
      "index": 0,
      "logprobs": null,
      "message": {
        "content": "{\"status\":\"PARTIAL\",\"explanation\":\"Singapore requires submission of long-term stability data, typically at 30°C/75% RH (ASEAN zone IVb), and generally does not accept 25°C/60% RH data unless fully justified; accelerated studies alone are not sufficient for approval[5][1].\"}",
        "refusal": null,
        "role": "assistant",
        "annotations": null,
        "audio": null,
        "function_call": null,
        "tool_calls": null
      },
      "delta": {
        "role": "assistant",
        "content": ""
      }
    }
  ],
  "created": 1755750290,
  "model": "sonar-pro",
  "object": "chat.completion",
  "service_tier": null,
  "system_fingerprint": null,
  "usage": {
    "completion_tokens": 65,
    "prompt_tokens": 31,
    "total_tokens": 96,
    "completion_tokens_details": null,
    "prompt_tokens_details": null,
    "search_context_size": "low",
    "cost": {
      "input_tokens_cost": 0.0,
      "output_tokens_cost": 0.001,
      "request_cost": 0.006,
      "total_cost": 0.007
    }
  },
  "citations": [
    "https://asean.org/wp-content/uploads/i-Final-ASEAN-Guideline-on-Stability-Study-Drug-Product-R2_uniformed-template.pdf",
    "https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-stability-testing-stability-testing-existing-active-substances-and-related-finished-products_en.pdf",
    "http://academy.gmp-compliance.org/guidemgr/files/WHO_TRS_953_Annex2.pdf",
    "https://database.ich.org/sites/default/files/Q1A(R2)%20Guideline.pdf",
    "https://www.hsa.gov.sg/docs/default-source/hprg-tpb/guidances/guidance-on-therapeutic-product-registration-in-singapore.pdf?sfvrsn=cd174383_52"
  ],
  "search_results": [
    {
      "title": "i-Final-ASEAN-Guideline-on-Stability-Study-Drug-Product- ...",
      "url": "https://asean.org/wp-content/uploads/i-Final-ASEAN-Guideline-on-Stability-Study-Drug-Product-R2_uniformed-template.pdf",
      "date": null,
      "last_updated": "2025-08-10"
    },
    {
      "title": "[PDF] Stability testing of existing active substances and related finished ...",
      "url": "https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-stability-testing-stability-testing-existing-active-substances-and-related-finished-products_en.pdf",
      "date": null,
      "last_updated": "2025-08-10"
    },
    {
      "title": "Annex 2 Stability testing of active pharmaceutical ...",
      "url": "http://academy.gmp-compliance.org/guidemgr/files/WHO_TRS_953_Annex2.pdf",
      "date": null,
      "last_updated": "2025-08-10"
    },
    {
      "title": "[PDF] Q1A(R2) Guideline - ICH",
      "url": "https://database.ich.org/sites/default/files/Q1A(R2)%20Guideline.pdf",
      "date": null,
      "last_updated": "2025-08-10"
    },
    {
      "title": "guidance-on-therapeutic-product-registration-in-singapore. ...",
      "url": "https://www.hsa.gov.sg/docs/default-source/hprg-tpb/guidances/guidance-on-therapeutic-product-registration-in-singapore.pdf?sfvrsn=cd174383_52",
      "date": null,
      "last_updated": "2025-08-12"
    }
  ]
}